Preconditioning with latrepirdine, an adenosine 5′-monophosphate (AMP)-activated protein kinase activator, was beneficial in the SOD1 mouse model of ALS (Coughlan et al., 2015). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.